Browse Related Topics For:

Hatch-Waxman

126
Pharmaceutical Industry
120
Patents
117
Generic Drugs
100
Pharmaceutical Patents
95
Patent Infringement
82
Patent Litigation
79
ANDA
64
FDA
63
Prescription Drugs
34
SCOTUS
32
FTC
32
FTC v Actavis
31
Reverse Payment Settlement Agreements
18
Pay-For-Delay
15
BPCIA
15
Mylan Pharmaceuticals
14
Antitrust Litigation
14
Personal Jurisdiction
14
Popular
13
Biosimilars
13
Inter Partes Review Proceedings
13
Teva Pharmaceuticals
10
Actavis Inc.
10
Patent Trial and Appeal Board
10
Sandoz
9
AstraZeneca
9
Safe Harbors
9
Settlement
8
America Invents Act
8
Anti-Competitive
7
Apotex
7
Biologics
7
Cephalon
7
Claim Construction
7
DaimlerChrysler v Bauman
7
Rule-of-Reason Analysis
6
Appeals
6
Declaratory Judgments
6
Eli Lilly
6
FDCA
6
Otsuka Pharmaceutical
6
Prior Art
6
Sandoz v Amgen
6
Sherman Act
6
USPTO
6
Watson Pharmaceuticals
5
Amgen
5
Classen Immunotherapies
5
Corporate Counsel
5
FDA Approval
5
GlaxoSmithKline
5
Infringement
5
No-AG Agreement
5
Novartis
5
Obviousness
5
Patent Applications
5
Patent Reform
5
Patent-in-Suit
5
Preliminary Injunctions
5
Teva v Sandoz
4
Endo Pharmaceuticals
4
Merck
4
Motion to Dismiss
4
Orange Book
4
Patent Invalidity
4
Pleading Standards
4
Preemption
4
Standard of Review
3
Biologics Price Competition and Innovation Act of 2009
3
Biotechnology
3
Class Action
3
De Novo Standard of Review
3
Discovery
3
Disgorgement
3
Dismissals
3
Elan Pharmaceuticals
3
Healthcare
3
Hedge Funds
3
Hospira
3
Induced Infringement
3
Innovation Act
3
Jurisdiction
3
Labeling
3
Minimum Contacts
3
Patent Dance
3
Patent Trolls
3
Patent-Eligible Subject Matter
3
Product Hopping
3
Putative Class Actions
3
Reverse Payments
3
Specific Jurisdiction
3
Standing
3
Summary Judgment
3
Takeda Pharmaceuticals
3
Unfair Competition
3
Warner Chilcott
2
aBLA
2
Allergan Inc
2
Amarin
2
Antitrust Provisions
2
Antitrust Violations
2
Article III
2
Biogen Idec
2
Burden of Proof
2
CA Supreme Court
2
Cartwright Act
2
Commercial Marketing
2
DaimlerAG
2
Damages
2
Disclosure Requirements
2
Doctrine of Equivalents
2
Exclusivity
2
Failure To Warn
2
Federal Rule 12(b)(6)
2
Forum Shopping
2
Generic
2
Injunctions
2
Innovation
2
Intellectual Property Litigation
2
Intellectual Property Protection
2
Life Sciences
2
Manufacturers
2
Medicare Modernization Act
2
Monopolization
2
Motion To Stay
2
Mutual Pharmaceuticals v Bartlett
2
Non-Practicing Entities
2
Noninfringement
2
Notice Requirements
2
PLIVA v Mensing
2
Presumption of Validity
2
Proposed Regulation
2
Shire Development v Watson
2
Spectrum
2
Subject Matter Jurisdiction
2
Validity
2
Written Descriptions
1
Abbott Laboratories
1
Abuse of Process
1
Affordable Care Act
1
Allergan v Sandoz
1
Amicus Briefs
1
AMP v Myriad
1
Annual Reports
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Injuries
1
Antitrust Standing
1
Attorney Disbarrment
1
Attorney-Client Privilege
1
Australia
1
Automatic Stay
1
Balancing Test
1
Bayer
1
Bifurcation
1
Biofuel
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Bowman v Monsanto
1
Brand
1
Broadest Reasonable Interpretation Standard
1
Burden-Shifting
1
But For Causation
1
CAFA
1
Cancer
1
Certiorari
1
Chevron Deference
1
Cipro
1
Cisco v CommilUSA
1
Claim Preclusion
1
Class Certification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
CLS Bank v Alice Corp
1
Coca Cola
1
Collateralized Debt Obligations
1
Combination Products
1
Comment Period
1
Competition
1
Compliance
1
Congressional Committees
1
Consent Order
1
Consideration
1
Contraceptives
1
Controlled Substances Act
1
Counterclaims
1
Covered Business Method Patents
1
Covered Business Method Proceedings
1
Cuozzo Speed Technologies
1
Dart Cherokee Basin Operating Co. v. Owens
1
Data Protection
1
DEA
1
Death Penalty
1
Dell
1
Design Defects
1
Design Patent
1
Direct Purchasers
1
Dirks v SEC
1
Discovery Schedule
1
DNA
1
Drug Approvals
1
Drug Compounding
1
Drug Safety
1
Duty to Deal
1
eBay
1
Emerging Markets
1
Employer Mandates
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
EPA
1
Estoppel
1
European Patent Office
1
Exemptions
1
Expert Testimony
1
Exports
1
Extrinsic Evidence
1
Fair Market Value
1
False Advertising
1
Federal Jurisdiction
1
Federal Rules of Civil Procedure
1
Financial Crisis
1
Foreign Corporations
1
Foreign Defendants
1
Forum
1
Forum Non Conveniens
1
Forum Selection
1
Fraud
1
Fresenius
1
General Jurisdiction
1
Genzyme
1
Goodyear
1
Healthcare Costs
1
Hindsight Reconstruction
1
Human Genes
1
India
1
Injury-in-Fact
1
Innovator Liability
1
Insider Trading
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Internal Investigations
1
Inventions
1
ITC
1
Jazz Pharmaceuticals
1
Joinder
1
Justiciable Controversy
1
KBR (formerly Kellogg Brown & Root)
1
Laches
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Licensing Rules
1
Loss Causation
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Markman Hearing
1
Material Misrepresentation
1
Mayo v. Prometheus
1
Medical Devices
1
Medical Research
1
Misrepresentation
1
Monsanto
1
Morgan Stanley
1
Motion for Reconsideration
1
Motion to Amend
1
Myriad
1
New Trial
1
Nexium
1
Nintendo
1
Off-Label Use
1
Omissions
1
Omnicare v Laborers District Council
1
On-Sale Bar
1
Orphan Drugs
1
Out-of-State Companies
1
OxyContin
1
Par Pharmaceutical
1
Patent Agent Privilege
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent-Misuse
1
Patentability Search
1
Pending Legislation
1
Permanent Injunctions
1
Personal Benefit
1
Petition For Rehearing
1
Pfizer
1
PHRMA
1
Pleadings
1
POM Wonderful
1
Post-Grant Review
1
Premarket Approval Applications
1
Presidential Elections
1
Price Manipulation
1
Prilosec
1
Prioritized Examination
1
Privilege Waivers
1
Proctor & Gamble
1
Product Exclusivity
1
Product Labels
1
Professional Conferences
1
Prometheus
1
Proposed Amendments
1
Quality Control Plan
1
RanBaxy
1
Registration Requirement
1
Regulatory Agenda
1
Reissue Patents
1
Removal
1
Research and Development
1
Restraining Orders
1
Reversal
1
RICO
1
Ripeness
1
ROI
1
Roxane Laboratories
1
Royalties
1
Rule 26
1
Rulemaking Process
1
Sales Contracts
1
Scienter
1
Scope of Discovery Requests
1
Section 337
1
Settlements
1
Sham Litigation Exception
1
Single Occurrence
1
SmithKline Beecham
1
SNDAs
1
Standard of Proof
1
State Law Tort Claims
1
STRONG Patents Act
1
Supplemental Examination
1
Supply Chain
1
Tolling
1
Trademark Infringement
1
TRIPS Agreement
1
TRO
1
USDA
1
Vacated
1
Vaccinations
1
Valuation
1
Veterinarians
1
Veterinary Products
1
White Collar Crimes
1
WIPO
1
Work Product Privilege
1
World Intellectual Property Organisation